A total of 496 patients (with 362 gliomas including 176 glioblastomas and 134 meningiomas) were included in the study (see Section 2.3.5 and Section 2.4.8 “Brain Tumors” regardingNOS1 and NOS2). This evidence concerns the gene NOS2 and brain neoplasm.